A Study of an Oral Entry Inhibitor, SP01A, in Treatment-Experienced HIV-Infected Patients
Clinical trial NCT00113412 · UNKNOWN
Trial details
- NCT number
- NCT00113412
- Sponsor
- Samaritan Pharmaceuticals, Inc
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-05-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.